BioAtla, Inc. — Director's Dealing 2022

Feb 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2021-12-16

Reporting Person: Williams Eddie (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-16	Stock Option (Right to Buy)	$19.57	A	25000	Acquired	2031-12-16	Common Stock (25000)	Direct

Footnotes

F1: The Option will vest and become exercisable as follows: (i) 8,333 Shares will vest Shares on the first anniversary of the date of grant, (ii) 694 Shares on the last day of the next 23 months commencing with the month next following such first anniversary and (iii) 705 Shares on the last day of the 24th month next following such first anniversary, subject to Mr. Williams continuing to provide services to the Company through the vesting date.